RealD, which is expected to go public this week, said Tuesday that it signed an agreement with a large eyewear maker to create a RealD-branded line of 3D glasses that will include prescription 3D lenses.

The Beverly Hills developer of 3D movie projection technology said Marchon Eyewear Inc. of Melville, N.Y., is purchasing the 3D unit of MicroVision Optical in San Diego to enable it to launch the 3D product line. The unit, to be renamed Marchon3D, will make and distribute 3D glasses at movie theaters, retail locations, and other venues.

In addition to standard 3D glasses, Marchon3D will offer a prescription 3D lens. Both types of 3D eyewear will work not only in RealD-enabled theaters, but also with compatible passive-system 3D televisions, laptops and monitors. Another feature of the eyewear is that the lenses will block UVA and UVB rays and can be used as sunglasses. Retail prices for the glasses and date of launch were not announced.

“RealD is committed to providing moviegoers with a premium 3D viewing experience,” Joseph Peixoto, president of Worldwide Cinema at RealD, said in a statement. “We understand that just as movie selection is a reflection of personal taste, some RealD 3D fans want a choice of 3D eyewear that fits their personal style.”

RealD earlier this month set a pricing range between $13 and $15 per share for an expected $151 million initial public offering, much of which will be stock sold by insiders.

If the offering sells at the mid-point of the range, RealD will have a market cap of nearly $788 million.